Matthew R. Henn Seres Therapeutics, Inc. (MCRB) insider trading activity

Matthew R. Henn is of Seres Therapeutics, Inc.. Currently has a direct ownership of 77,770 shares of MCRB, which is worth approximately $59,882. The most recent transaction as insider was on Nov 18, 2024, when has been sold 927 shares (Common Stock) at a price of $0.54 per share, resulting in proceeds of $500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 77.8K

15.65% 3M change

38.0% 12M change

Total Value Held $59,882

Matthew R. Henn Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 18 2024	SELL Open market or private sale	$500 $0.54 p/Share	927 Reduced 1.18%	77,770 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	2,812 Added 3.45%	78,697 Common Stock
Oct 28 2024	SELL Open market or private sale	$2,748 $0.69 p/Share	3,984 Reduced 4.99%	75,885 Common Stock
Oct 27 2024	BUY Exercise of conversion of derivative security	-	12,622 Added 13.65%	79,869 Common Stock
Aug 16 2024	SELL Open market or private sale	$775 $0.84 p/Share	923 Reduced 1.35%	67,247 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 3.96%	68,170 Common Stock
May 15 2024	SELL Open market or private sale	$837 $0.94 p/Share	891 Reduced 1.34%	65,357 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	2,812 Added 4.07%	66,248 Common Stock
Feb 16 2024	SELL Open market or private sale	$4,503 $1.08 p/Share	4,170 Reduced 6.17%	63,436 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	11,250 Added 14.27%	67,606 Common Stock
Oct 30 2023	SELL Open market or private sale	$5,246 $1.35 p/Share	3,886 Reduced 6.45%	56,356 Common Stock
Oct 27 2023	BUY Exercise of conversion of derivative security	-	12,623 Added 17.32%	60,242 Common Stock
Jul 05 2022	BUY Grant, award, or other acquisition	$150,000 $3.15 p/Share	47,619 Added 50.0%	47,619 Common Stock
Dec 01 2020	SELL Open market or private sale	$2,523,912 $27.49 p/Share	91,812 Reduced 100.0%	0 Common Stock
Dec 01 2020	BUY Exercise of conversion of derivative security	$442,158 $5.54 p/Share	79,812 Added 46.5%	91,812 Common Stock

MRH

Matthew R. Henn

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MCRB shares.

Notify only if

Value

Insider Trading

Get notified when an Seres Therapeutics, Inc. insider buys or sells MCRB shares.

Notify only if

Operation

Value

Type

News

Receive news related to Seres Therapeutics, Inc.

Track Activities on MCRB

Account